Satake Yoshiyuki

Tomida Daisuke, Yagi-Yaguchi Yukari, Higa Kazunari, Satake Yoshiyuki, Shimazaki Jun, Yamaguchi Takefumi

This study found tear and aqueous humor cytokine levels correlate only in bullous keratopathy, suggesting tears may reflect intraocular inflammation in these patients.

Yazu Hiroyuki, Yamaguchi Takefumi, Aketa Naohiko, Higa Kazunari, Suzuki Terumasa, Yagi-Yaguchi Yukari et al.

Higher preoperative aqueous inflammatory cytokines (IL-17A, MCP-1, IFN-γ, E-selectin, sICAM-1) predict greater endothelial cell loss after DSAEK, suggesting inflammation impacts graft survival.

Aketa Naohiko, Yamaguchi Takefumi, Asato Teru, Yagi-Yaguchi Yukari, Suzuki Terumasa, Higa Kazunari et al.

This study found chronic ocular surface diseases elevate specific aqueous humor cytokines, indicating persistent inflammation that could impact intraocular surgery outcomes or glaucoma management.

Yagi-Yaguchi Yukari, Yamaguchi Takefumi, Higa Kazunari, Suzuki Terumasa, Yazu Hiroyuki, Aketa Naohiko et al.

Preoperative aqueous humor inflammation (IL-10, MCP-1, IFN-γ) predicts lower corneal endothelial cell density after penetrating keratoplasty, indicating potential for identifying high-risk patients.

Aketa Naohiko, Yamaguchi Takefumi, Suzuki Terumasa, Higa Kazunari, Yagi-Yaguchi Yukari, Satake Yoshiyuki et al.

Iris damage correlates with elevated aqueous humor inflammatory cytokines, indicating localized inflammation. This suggests iris health impacts the ocular inflammatory environment, potentially influencing glaucoma management.

Yamaguchi Takefumi, Higa Kazunari, Suzuki Terumasa, Nakayama Naohiko, Yagi-Yaguchi Yukari, Dogru Murat et al.

Aqueous humor cytokine levels are elevated in bullous keratopathy and low endothelial cell density eyes, suggesting subclinical inflammation may drive endothelial cell loss.

Shimazaki Jun, Iseda Ayumi, Satake Yoshiyuki, Shimazaki-Den Seika

Long-term 0.1% fluorometholone eye drops after penetrating keratoplasty significantly reduced endothelial rejection without increased side effects, suggesting continued use is beneficial for graft survival.